Skip to main content
. 2026 Jun 4;15(6):573. doi: 10.3390/antibiotics15060573
AKI Acute Kidney Injury
APACHE II Acute Physiology and Chronic Health Evaluation II
ARC Augmented Renal Clearance
AUC Area Under the Concentration–Time Curve
CI Confidence Interval
CKD-EPI Chronic Kidney Disease Epidemiology Collaboration
eGFR Estimated Glomerular Filtration Rate
HAP Hospital-Acquired Pneumonia
ICU Intensive Care Unit
KDIGO Kidney Disease: Improving Global Outcomes
MIC Minimum Inhibitory Concentration
MRSA Methicillin-Resistant Staphylococcus aureus
OR Odds Ratio
PK/PD Pharmacokinetic/Pharmacodynamic
SAPS Simplified Acute Physiology Score
sCAP severe Community-Acquired Pneumonia
SD Standard Deviation
SOFA Sequential Organ Failure Assessment
TDM Therapeutic Drug Monitoring
TIR Time in Therapeutic Range
VAP Ventilator-Associated Pneumonia
VRE Vancomycin-Resistant Enterococcus
VTC Vancomycin Trough Concentration